Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
about
Paraneoplastic neurological complications of breast cancer.Autoantibodies as potential biomarkers for breast cancer.Autoantibodies to tumor-associated antigens in epithelial ovarian carcinoma.Tumour auto-antibody screening: performance of protein microarrays using SEREX derived antigens.Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis.Autoantibodies to tumor-associated antigens in breast carcinoma.Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.The tumor-immune microenvironment and response to radiation therapyLeukocytes in mammary development and cancer.Autoantibodies against muscarinic receptors in breast cancer: their role in tumor angiogenesis.Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancerLatest updates on antiretinal autoantibodies associated with vision loss and breast cancer.Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review).Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.Tumor-associated antigen arrays for the serological diagnosis of cancer.Expression of odontogenic ameloblast-associated protein (ODAM) in dental and other epithelial neoplasms.Molecular biomarkers for cancer detection in blood and bodily fluids.Breast cancer proteomics: clinical perspectives.Shared immunoproteome for ovarian cancer diagnostics and immunotherapy: potential theranostic approach to cancer.Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathySerum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinomaCirculating autoantibodies to LGALS3BP: a novel biomarker for cancer.Serologic laboratory findings in malignancy.Optical imaging of the peri-tumoral inflammatory response in breast cancer.Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinomaSerum autoantibodies as biomarkers for early cancer detection.Serum APE1 as a predictive marker for platinum-based chemotherapy of non-small cell lung cancer patientsα-Enolase: a promising therapeutic and diagnostic tumor target.Dendritic cell-based vaccine research against cancer.Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis.Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice.[Autoantibodies as the early diagnostic biomarkers for lung cancer].
P2860
Q28077708-31A183AB-B057-4805-BB8A-9BDE0C995FEEQ33332063-15683142-0138-42F6-B9D2-DB2299B8CA90Q33633387-7B6901B2-F760-4B2A-90D6-2C6F90136C1EQ33747137-F87B4109-FCC5-4FE1-85C4-92AACF93AC54Q33967422-858C41D2-B314-49F3-AD15-7DC6D6240CA5Q34049184-385A3436-A567-48C7-9B93-8C54CEAE42D7Q34309299-57FD405C-6F56-4CFB-A1A5-0C53DADF6E63Q34339160-125F51C4-5EFF-4F17-836B-58A09E6EAD4AQ34347517-161156B9-1F2D-42B9-A776-F54A378F25A4Q34444598-274543AC-1C10-4976-9215-3CB0CC2ABFFEQ34578021-A5101EF4-D3A7-4EDE-A128-F0A755FE8ED6Q34608685-9873016E-6DF4-498B-ADA4-6F9E0A39F1B2Q34614608-18842A9E-F166-4628-8A10-B56F516324E5Q35161069-A80F64E9-8BD3-4D7D-AAB7-2B97075C8322Q35632045-BBC3A24B-51AD-4EDA-8187-28D11465BFF8Q35840714-75DF4FDC-8088-4DFD-816A-324939DDB885Q35934485-18A05263-FA8E-4B24-A9A4-F76E8F22EF10Q36393268-38372D1D-0CC0-47A6-B9D9-BB180FEA5023Q36407199-6814A6DA-E82B-4B7C-B0D5-2FA4E6CAFBE6Q36491988-94FBB429-68E6-4E2B-814E-AEA5022C6946Q36570772-6B4E10BF-AB82-4386-BE6F-3394BB7E11B4Q36627755-05ABE039-BDDD-45D1-BFE5-B2EF26DD0087Q36717346-5A755BC9-8B7E-4DC9-A6D5-EA248E40EA2BQ36871710-9458F4C6-3E58-49AD-A220-231607F6CA31Q37188746-334428C3-ED2E-473A-A52A-864BED16F716Q37212230-957E2150-CA2D-46E9-B465-2F626D6DDCEAQ37363290-5B96E4E5-2A89-4440-A3F3-370B19899AA6Q37401677-FA19BEAB-B7A2-4F31-86B0-E48B2FDA723BQ37429591-E005C4F9-86FB-4E1E-84D8-D2A26A4D8C09Q37460909-2D9B1921-958A-453B-A0A3-FD5BEE9E5A6FQ37622471-1E4BAED1-392E-4FA1-BCCF-F14ECDCB6D38Q37684604-75821CAB-E745-481A-9228-E9E7E38374B7Q37831975-6803C9B4-4240-47C9-B8F8-8469FE32676DQ38281782-AE6C10DD-B9C7-4F41-9E90-0D021CA089D5Q38331911-C1234A1F-FADE-446C-8BFE-976AE46338DEQ38780263-FB38F28C-69BD-43ED-AC7C-5531DF1AF1BCQ39617426-11946706-B0E0-4AC0-924F-FD6387EEE8E3Q55436520-F654773F-DD9E-4BC8-9079-5B9005F4E7B8
P2860
Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Autoantibodies in breast cance ...... nd reporters of tumorigenesis.
@ast
Autoantibodies in breast cance ...... nd reporters of tumorigenesis.
@en
type
label
Autoantibodies in breast cance ...... nd reporters of tumorigenesis.
@ast
Autoantibodies in breast cance ...... nd reporters of tumorigenesis.
@en
prefLabel
Autoantibodies in breast cance ...... nd reporters of tumorigenesis.
@ast
Autoantibodies in breast cance ...... nd reporters of tumorigenesis.
@en
P1433
P1476
Autoantibodies in breast cance ...... nd reporters of tumorigenesis.
@en
P2093
Félix Fernández Madrid
P304
P356
10.1016/J.CANLET.2004.12.017
P407
P577
2005-01-18T00:00:00Z